Holen Sie sich die Stockscreener-App
0.1143
6.08%
-0.0074
Vorhandelsmarkt:
.09
-0.0243
-21.26%
Schlusskurs vom Vortag:
$0.1217
Offen:
$0.1198
24-Stunden-Volumen:
8.06M
Relative Volume:
0.66
Marktkapitalisierung:
$6.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.78M
KGV:
-0.00268
EPS:
-42.6996
Netto-Cashflow:
$-4.67M
1W Leistung:
+2.88%
1M Leistung:
-83.16%
6M Leistung:
-87.24%
1J Leistung:
-91.41%
1-Tages-Spanne:
$0.1141
$0.1198
1-Wochen-Bereich:
$0.11
$0.1315
52-Wochen-Spanne:
$0.10
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Firmenname
Clearmind Medicine Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CMND mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
0.1143 | 7.30M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clearmind Medicine Inc Aktie (CMND) Neueste Nachrichten
Clearmind Medicine to implement 1-for-40 reverse stock split By Investing.com - Investing.com Australia
Clearmind Medicine to implement 1-for-40 reverse stock split - Investing.com
Clearmind Medicine to enact 1-for-40 reverse share split; shares down - MSN
Clearmind Medicine Inc. Announces 1-for-40 Reverse Share Split to Regain Nasdaq Compliance - Quiver Quantitative
Clearmind Medicine Announces 1-for-40 Reverse Share Split - The Manila Times
Clearmind Medicine Announces 1-for-40 Reverse Share Split | Associated Press | syndication news - Enidnews.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification - marketscreener.com
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Clearmind Medicine Shares Surge After Securing Final Approval for AUD Drug Trial Site - MSN
Clearmind Medicine announces receipt of Nasdaq minimum bid price notification - MSN
Clearmind Medicine reports regaining Nasdaq equity compliance after financings - Investing.com
Clearmind Medicine reports regaining Nasdaq equity compliance after financings By Investing.com - Investing.com Australia
Clearmind Medicine Inc. Receives Nasdaq Compliance Notice Regarding Minimum Bid Price Requirement - Quiver Quantitative
Clearmind Medicine stock drops after Nasdaq compliance notice By Investing.com - Investing.com South Africa
Clearmind Medicine stock drops after Nasdaq compliance notice - Investing.com
Is Clearmind Medicine Inc. stock near bottom after declineWeekly Loss Report & High Return Stock Watch Alerts - Newser
Will Clearmind Medicine Inc. stock outperform tech sector in 2025July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
How Clearmind Medicine Inc. (CWY0) stock behaves under inflation pressureWeekly Gains Report & Low Risk Entry Point Tips - Newser
Clearmind Medicine Inc files for offering of up to 16 million common sharesSEC filing - marketscreener.com
What MACD trends signal for Clearmind Medicine Inc. (CWY0) stock - Newser
Is Clearmind Medicine Inc. (CWY0) stock a good hedge against inflationJuly 2025 Levels & Risk Managed Investment Signals - Newser
Can Clearmind Medicine Inc. (CWY0) stock double in coming yearsJuly 2025 Earnings & Verified High Yield Trade Plans - Newser
Clearmind enrolls first participant in AUD trial at Hadassah Medical - Investing.com India
Clearmind enrolls first participant in AUD trial at Hadassah Medical By Investing.com - Investing.com Canada
Clearmind Medicine advances CMND-100 to dosing phase at Hadassah Medical Center - marketscreener.com
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder - The Manila Times
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Clearmind Medicine (CMND) Stock Analysis Report | Financials & Insights - Benzinga
Clearmind reports positive results in alcohol disorder treatment trial By Investing.com - Investing.com Nigeria
Clearmind reports positive results in alcohol disorder treatment trial - Investing.com
Clearmind Medicine Inc. Reports Key Milestones in Phase I/IIa Trial for Alcohol Use Disorder Treatment CMND-100 - Quiver Quantitative
Clearmind advances alcoholism treatment with positive data, DSMB approval, and new trial site - marketscreener.com
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial - The Manila Times
What drives Clearmind Medicine Inc stock priceInsider Buying Signals & Superior Capital Appreciation - earlytimes.in
Clearmind Medicine schedules annual and special shareholder meeting for December - Investing.com India
Clearmind kicks off patient enrollment at Tel Aviv Sourasky Medical Center - MSN
Why Did Clearmind Medicine Shares Jump 7% In Pre-Market Trading? - Sahm
Tel Aviv Sourasky Medical Center enrolls first patient in Clearmind’s AUD trial - Investing.com Nigeria
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial - The Manila Times
Finanzdaten der Clearmind Medicine Inc-Aktie (CMND)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):